JP2013520407A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520407A5
JP2013520407A5 JP2012553435A JP2012553435A JP2013520407A5 JP 2013520407 A5 JP2013520407 A5 JP 2013520407A5 JP 2012553435 A JP2012553435 A JP 2012553435A JP 2012553435 A JP2012553435 A JP 2012553435A JP 2013520407 A5 JP2013520407 A5 JP 2013520407A5
Authority
JP
Japan
Prior art keywords
pyrazolo
hexahydro
pyridin
benzyl
chlorobenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012553435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520407A (ja
Filing date
Publication date
Priority claimed from EP10153929A external-priority patent/EP2361912A1/en
Application filed filed Critical
Publication of JP2013520407A publication Critical patent/JP2013520407A/ja
Publication of JP2013520407A5 publication Critical patent/JP2013520407A5/ja
Pending legal-status Critical Current

Links

JP2012553435A 2010-02-18 2011-02-17 Nadphオキシダーゼ阻害剤としてのピラゾロピペリジン誘導体 Pending JP2013520407A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10153929A EP2361912A1 (en) 2010-02-18 2010-02-18 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
EP10153929.4 2010-02-18
PCT/IB2011/050668 WO2011101805A1 (en) 2010-02-18 2011-02-17 Pyrazolo piperidine derivatives as nadph oxidase inhibitors

Publications (2)

Publication Number Publication Date
JP2013520407A JP2013520407A (ja) 2013-06-06
JP2013520407A5 true JP2013520407A5 (enExample) 2014-04-03

Family

ID=42635178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012553435A Pending JP2013520407A (ja) 2010-02-18 2011-02-17 Nadphオキシダーゼ阻害剤としてのピラゾロピペリジン誘導体

Country Status (11)

Country Link
US (1) US8748456B2 (enExample)
EP (2) EP2361912A1 (enExample)
JP (1) JP2013520407A (enExample)
KR (1) KR20130002317A (enExample)
CN (1) CN102762562A (enExample)
AU (1) AU2011216894A1 (enExample)
BR (1) BR112012020742A2 (enExample)
CA (1) CA2789408A1 (enExample)
IL (1) IL221209A0 (enExample)
RU (1) RU2012139830A (enExample)
WO (1) WO2011101805A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2002835A1 (en) 2007-06-04 2008-12-17 GenKyo Tex Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2165707A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166010A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166008A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166009A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as nadph oxidase inhibitors
EP2305679A1 (en) 2009-09-28 2011-04-06 GenKyoTex SA Pyrazoline dione derivatives as nadph oxidase inhibitors
EP2361911A1 (en) 2010-02-18 2011-08-31 GenKyoTex SA Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
GB2494679A (en) 2011-09-15 2013-03-20 Univ Jw Goethe Frankfurt Main Treatment of neuropathic pain and nerve injury by Nox4 inhibition
IN2015DN03761A (enExample) 2012-10-24 2015-10-02 Glucox Biotech Ab
WO2014186704A2 (en) * 2013-05-17 2014-11-20 N30 Pharmaceuticals, Inc. Novel compounds for the treatment of cystic fibrosis
CN105315275B (zh) * 2014-07-14 2019-10-01 中国科学院上海药物研究所 一类吡唑酮化合物及其用途
EP3258937A4 (en) 2015-02-16 2018-10-31 Glucox Biotech AB N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine
EP3479843A1 (en) 2017-11-01 2019-05-08 GenKyoTex Suisse SA Use of nox inhibitors for treatment of cancer
AU2020289560A1 (en) 2019-06-05 2021-12-23 Emory University Peptidomimetics for the treatment of coronavirus and picornavirus infections
WO2021145655A1 (ko) * 2020-01-13 2021-07-22 압타바이오 주식회사 신규한 피라졸 유도체
CN115916766A (zh) * 2021-02-25 2023-04-04 阿普塔生物治疗公司 新型吡唑衍生物
CN121816351A (zh) * 2023-07-10 2026-04-07 苏州安赛隆医药科技有限公司 人源酪蛋白水解蛋白酶p激动剂及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
CA2383466C (en) * 1999-09-16 2009-08-25 Tanabe Seiyaku Co., Ltd. Aromatic nitrogen-containing 6-membered cyclic compounds
IL144468A0 (en) * 2000-07-27 2002-05-23 Pfizer Prod Inc Use of growth hormone secretagogues for improvement of functional health status
JP2004217654A (ja) * 2002-12-27 2004-08-05 Japan Tobacco Inc 縮合n含有へテロ環化合物及びその医薬用途
US7759337B2 (en) * 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
EP1968976A1 (en) * 2005-12-12 2008-09-17 NERVIANO MEDICAL SCIENCES S.r.l. Substituted pyrazolo [4,3-c] pyridine derivatives active as kinase inhibitors
EP2002835A1 (en) * 2007-06-04 2008-12-17 GenKyo Tex Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
WO2009072643A1 (en) * 2007-12-03 2009-06-11 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound and use thereof
MY155244A (en) * 2008-12-29 2015-09-30 Sanofi Sa Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
EP2361911A1 (en) 2010-02-18 2011-08-31 GenKyoTex SA Pyrazolo piperidine derivatives as NADPH oxidase inhibitors

Similar Documents

Publication Publication Date Title
RU2012139830A (ru) Производные пиразолопиперидина в качестве ингибиторов nadph - оксидазы
JP2013519724A5 (enExample)
AU2009288399B2 (en) Hedgehog pathway modulators
JP5808793B2 (ja) キナーゼ調節のための化合物および方法、ならびにそれらの適応症
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2013515032A5 (enExample)
JP2017510576A5 (enExample)
JP2016500671A5 (enExample)
JP2020527560A5 (enExample)
WO2014078813A1 (en) Compounds and compositions for the treatment of parasitic diseases
RU2012139828A (ru) Производные пиразолопиперидина в качестве ингибиторов nadph-оксидазы
JP2015511245A5 (enExample)
JP2017535536A5 (enExample)
JP2016538316A5 (enExample)
JP2014511884A5 (enExample)
JP2007509141A5 (enExample)
JP2005526029A (ja) 細胞増殖が関与する疾患を治療するためのキノリノン誘導体
RU2005136429A (ru) Производные азаспироалканов в качестве тнгибиторов металлопротеаз
RU2018123779A (ru) Новые соединения
JP2022500402A5 (enExample)
RU2404163C2 (ru) Производные 2,3,4,9-тетрагидро-1h-карбазола в качестве антагонистов рецептора crth2
JP2020510092A5 (enExample)
JP2014511885A5 (enExample)
CN106132956A (zh) 一类杂环化合物、其制备方法和用途
US20060199817A1 (en) Phthalazine, aza- and diaza-phthalazine compounds and methods of use